1-3 of 3
Justin Huard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NEO-TRA1: A CD25-Targeted De Novo non-Alpha Agonist of the IL-2 Receptor Selectively Expands Regulatory T Cells

Alex Chen, Giacomo Tampella, Alfredo Quijano-Rubio, Matt Walker, Irene Barber, Justin Hare, Justin Huard, Danielle Van Citters, Aaron Moss, Hector Rincon, Bill Arthur
Journal: Blood
Blood (2022) 140 (Supplement 1): 1652–1653.
https://doi.org/10.1182/blood-2022-159254
Published: 2022
Journal Articles

NL-201, a De Novo Agonist of IL-2 and IL-15 Receptors, Demonstrates Synergistic Antitumor Activity with Anti-PD-1 Checkpoint Inhibitor Therapy in a Preclinical Non-Hodgkin Lymphoma Model

Justin Huard, Laurie Tatalick, Carl Walkey, Ryan Swanson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4560.
https://doi.org/10.1182/blood-2021-148885
Published: 2021
Journal Articles

AMG 900, a Potent and Highly Selective Aurora Kinase Inhibitor Shows Promising Preclinical Activity Against Acute Myeloid Leukemia Cell Lines In Vitro and In Vivo

Kam Cheung, Gloria Juan, William Wayne, Kelly Hanestad, Kathleen Keegan, Justin Huard, Patricia McElroy, Mary K Stanton, Tammy L Bush, Richard L Kendall, Robert Radinsky, Steve Abella, Peter C Pieslor, Gregory Friberg, Angela Coxon, Erick Gamelin, Marc Payton
Journal: Blood
Blood (2013) 122 (21): 3823.
https://doi.org/10.1182/blood.V122.21.3823.3823
Published: 2013